4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-301996
Chief Legal Officer sold 30,000 shares at an average $17.96 ($538,868)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazzariello Gina Chief Legal Officer | 2026-07-09 | Sale 10b5-1 | −15,000 | $18.32 | $274,746 | 194,090 | D: show line 1 in the form |
| Mazzariello Gina Chief Legal Officer | 2026-07-10 | Sale 10b5-1 | −15,000 | $17.61 | $264,122 | 179,090 | D: show line 2 in the form |
| Open-market sales · 30,000 sh · avg $17.96 · $538,868 | |||||||
Loading xslF345X06/ownership.xml…